Regorafenib monohydrate
| CAS No. | 1019206-88-2 | Cat. No. | BCP06668 |
| Name | Regorafenib monohydrate | ||
| Synonyms | BAY 734506 monohydrate; BAY734506 monohydrate; BAY-734506 monohydrate;BAY 73-4506 monohydrate;Regorafenib hydrate; | ||
| Formula | C21H17ClF4N4O4 | M. Wt | 500.83 |
| Description | Regorafenib hydrate is a hydrate that is the monohydrate form of anhydrous regorafenib. Used for for the treatment of metastatic colorectal cancer in patients who have previously received chemotherapy, anti-EGFR or anti-VEGF therapy. It has a role as an antineoplastic agent, a tyrosine kinase inhibitor and a hepatotoxic agent. It contains a regorafenib. | ||
| Related Products | 755037-03-7（Regorafenib） 835621-07-3（Regorafenib hydrochloride） | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase MAPK Pathway | ||
| Targets | PDGFR VEGFR RET Raf | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.